Impact of evidence-based guidelines on outcomes of hospitalized patients with clostridium difficile infection

Southern Medical Journal

Volumn 109, Issue 3, 2016, Pages 144-150

  Knaus, Stephen J ^a   Saum, Lindsay ^a   Cochard, Emily ^a   Prichard, Wesley ^a   Skinner, Brian ^a   Medas, Ryan ^a  

^a BUTLER UNIVERSITY   (United States)

Author keywords

Clostridium difficile; guidelines; hospital medicine; outcomes

Indexed keywords

COLESTYRAMINE; CREATININE; ENEMA; FIDAXOMICIN; METRONIDAZOLE; VANCOMYCIN;

AGED; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVIDENCE BASED PRACTICE; FEMALE; HEALTH CARE COST; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; ICD-9; INSTITUTIONAL CARE; LABORATORY TEST; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; RECURRENT DISEASE; RETROSPECTIVE STUDY; TEACHING HOSPITAL; TREATMENT DURATION; ECONOMICS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EVIDENCE BASED MEDICINE; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; TREATMENT OUTCOME;

AGED; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HOSPITALS, TEACHING; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT READMISSION; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84959884716     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.14423/SMJ.0000000000000428     Document Type: Article

References (16)

1. Magill SS, Edwards JR, Bamberg W, Multistate point-prevalence survey of health care-Associated infections. N Engl J Med 2014; 370: 1198-1208.
2. Lessa FC, Mu Y, Bamberg WM, Burden of Clostridium difficile infection in the United States. N Engl J Med 2015; 372: 825-834.
3. Forster AJ, Taljaard MT, Oake N, The effect of hospital-Acquired infection with Clostridium difficile on length of stay in hospital. CMAJ 2012; 184: 37-42.
4. Dubberke ER, Olsen MA,. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012; 5 (Suppl 2): S88-S92.
5. Zar FA, Bakkanagari SR, Moorthi KM, A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -Associated diarrhea, stratified by disease severity. Clin Infect Dis 2007; 45: 302-307.
6. Cohen SH, Gerding DN, Johnson S, Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-455.
7. McEllistrem MC, McGraw M, Sahud AG,. High frequency of nonadherence to Clostridium difficile treatment guidelines. South Med J 2014: 107597-599.
8. Saviteer SM, Samsa GP, Rutala WA,. Nosocomial infections in the elderly. Increased risk per hospital day. Am J Med 1988; 84: 661-666.
9. Johnson S, Louie TJ, Gerding DN, Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis 2014; 59: 345-354.
10. Drekonja DM, Butler M, MacDonald R, Comparative effectiveness of Clostridium difficile treatments: a systematic review. Ann Intern Med 2011; 155: 839-847.
11. Hensgens MP, Goorhuis A, Dekkers OM, Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 2012; 67: 742-748.
12. Surawicz CM, Brandt LJ, Binion DG, Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013; 108: 478-499.
13. Wenisch JM, Equiluz-Bruck S, Fudel M, Decreasing Clostridium difficile infections by an antimicrobial stewardship program that reduces moxifloxacin use. Antimicrob Agents Chemother 2014; 58: 5079-5083.
14. Talpaert MJ, Gopal Rao G, Cooper BS, Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother 2011; 66: 2168-2174.
15. Aldeyab MA, Kearney MP, Scott MG, An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother 2012; 67: 2988-2996.
16. Feazel LM, Malhotra A, Perencevich EN, Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-Analysis. J Antimicrob Chemother 2014; 69: 1748-1754.